Home / Top News / European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

GlobeNewswire

GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
GlobeNewswire